{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-24-016081","form_type":"8-K","ticker":"ATXI","cik":"0001644963","company_name":"AVENUE THERAPEUTICS, INC.","filed_at":"2024-05-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.401743+00:00","generated_at":"2026-06-02T02:22:59.570890+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Avenue Therapeutics enters $3.85M ATM equity offering agreement with H.C. Wainwright","bullets":["Company entered ATM offering agreement with H.C. Wainwright for up to $3,850,000 in common stock sales.","Manager receives 3.0% commission on gross proceeds; Company provides customary indemnification and contribution rights.","Offering is 'at the market' under Rule 415; Company may sell shares at its discretion over time.","Agreement terminates upon sale of all shares or earlier termination by either party on specified prior notice."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-24-016081","json":"https://secwatch.observer/filing/0001437749-24-016081.json","markdown":"https://secwatch.observer/filing/0001437749-24-016081.md","text":"https://secwatch.observer/filing/0001437749-24-016081.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1644963/000143774924016081/0001437749-24-016081-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1644963/000143774924016081/atxi20240510_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T02:22:59.570890+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"793fb5da6d1aed2030450954ac76e3e7a35b4c90","claim":"AVENUE THERAPEUTICS, INC. entered into At the Market Offering Agreement with H.C. Wainwright & Co. LLC valued at $3,850,000 (effective 2024-05-10).","evidence_excerpt":"On May 10, 2024, Avenue Therapeutics, Inc. (the “ Company ”) entered into an At the Market Offering Agreement (the “ Offering Agreement ”) with H.C. Wainwright & Co. LLC (the “ Manager ”) under which the Company may offer and sell, from time to time at its sole discretion, shares of its common stock","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1644963/000143774924016081/0001437749-24-016081-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"atm program"},{"label":"Counterparty","value":"H.C. Wainwright & Co. LLC"},{"label":"Value","value":"$3,850,000"},{"label":"Effective","value":"2024-05-10"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}